Friedegund Meier (F Meier)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

Systematic Review

Top Venues

Journal for immunotherapy of cancer

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Lukas Heinlein, Roman C Maron, Achim Hekler, Sarah Haggenmüller, Christoph Wies, Jochen Sven Utikal, Friedegund Meier, Sarah Hobelsberger, Frank F Gellrich, Mildred Sergon, Axel Hauschild, Lars Einar French, Lucie Heinzerling, Justin G Schlager, Kamran Ghoreschi, Max Schlaak, Franz J Hilke, Gabriela Poch, Sören Korsing, Carola Berking, Markus Vincent Heppt, Michael Erdmann, Sebastian Haferkamp, Konstantin Drexler, Dirk Schadendorf, Wiebke Sondermann, Matthias Goebeler, Bastian Schilling, Eva Krieghoff-Henning, Titus Josef Brinker
Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care. Communications medicine 4 (1) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hausschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hausschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hauschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hauschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hauschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hausschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Adi Diab, Helen J Gogas, Shahneen Sandhu, Georgina V Long, Paolo Antonio Ascierto, James M G Larkin, Mario Sznol, Fabio Franke, Tudor E Ciuleanu, Caio Pereira, Eva Muñoz Couselo, Fernanda Bronzon Damian, Michael Schenker, Aldo Perfetti, Celeste Lebbè, Gaëlle Quéreux, Friedegund Meier, Brendan D Curti, Carlos Rojas, Yull Arriaga, Haisu Yang, Ming Zhou, Shruthi Ravimohan, Paul Statkevich, Mary A Tagliaferri, Nikhil I Khushalani
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Andrea Gaißler, Jonas Bochem, Janine Spreuer, Shannon Ottmann, Alexander Martens, Teresa Amaral, Nikolaus Benjamin Wagner, Manfred Claassen, Friedegund Meier, Patrick Terheyden, Claus Garbe, Thomas Eigentler, Benjamin Weide, Graham P Pawelec, Kilian Wistuba-Hamprecht
Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma. Journal for immunotherapy of cancer 11 (6) (2023)
Omid Hamid, Jessica C Hassel, Alexander N Shoushtari, Friedegund Meier, Todd M Bauer, April K S Salama, John M Kirkwood, Paolo Antonio Ascierto, Paul C Lorigan, Cornelia Mauch, Marlana Orloff, Thomas R Jeffry Evans, Chris Holland, Ramakrishna Edukulla, Shaad E Abedin, Mark Ross Middleton
Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study. Journal for immunotherapy of cancer 11 (6) (2023)
Cindy Franklin, Peter Mohr, Leonie Bluhm, Friedegund Meier, Marlene Garzarolli, Michael Weichenthal, Katharina Kähler, Imke Grimmelmann, Ralf Gutzmer, Jochen Utikal, Patrick Terheyden, Rudolf Herbst, Sebastian Haferkamp, Claudia Pfoehler, Andrea Forschner, Ulrike Leiter, Fabian Ziller, Frank Meiss, Jens Ulrich, Alexander Kreuter, Christoffer Gebhardt, Julia Welzel, Bastian Schilling, Martin Kaatz, Karin Scharfetter-Kochanek, Edgar Dippel, Dorothee Nashan, Michael Sachse, Carsten Weishaupt, Harald Löffler, Thilo Gambichler, Carmen Loquai, Lucie Heinzerling, Stephan Grabbe, Dirk Debus, Gaston Schley, Jessica C Hassel, Gerhard Weyandt, Maike Trommer, Georg Lodde, Jan-Malte Placke, Lisa Zimmer, Elisabeth Livingstone, Jürgen Christian Becker, Susanne Horn, Dirk Schadendorf, Selma Ugurel
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG. Journal for immunotherapy of cancer 11 (4) (2023)
Elias A T Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Anja Gesierich, Ralf Gutzmer, Jessica C Hassel, Sebastian Haferkamp, Katharina C Kähler, Harald Knorr, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr, Claudia Pföhler, Farnaz Rahimi, Dirk Schadendorf, Beatrice Schell, Max Schlaak, Patrick Terheyden, Kai-Martin Thoms, Beatrice Schuler-Thurner, Selma Ugurel, Jens Ulrich, Jochen Sven Utikal, Michael Weichenthal, Fabian Ziller, Carola Berking, Markus Vincent Heppt
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity. Cancers 14 (3) (2022)
Theresa Steeb, Lydia Reinhardt, C Strasser, Anja Wessely, J Schelling, A Petzold, Markus Vincent Heppt, Friedegund Meier, Carola Berking
The need for regular training in skin cancer screening: a cross-sectional study among general practitioners in Germany. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (11) (2022)
Theresa Steeb, Lydia Reinhardt, Matthias Harlaß, Markus Vincent Heppt, Friedegund Meier, Carola Berking
Assessment of the Quality, Understandability, and Reliability of YouTube Videos as a Source of Information on Basal Cell Carcinoma: Web-Based Analysis. JMIR cancer 8 (1) (2022)
Peter Mohr, Emilie Scherrer, Chalid Assaf, Marc Bender, Carola Berking, Sheenu Chandwani, Thomas Kurt Eigentler, Imke Grimmelmann, Ralf Gutzmer, Sebastian Haferkamp, Jessica C Hassel, Axel Hauschild, Rudolf Herbst, Ruixuan Jiang, Katharina C Kähler, Clemens Krepler, Alexander Kreuter, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Claudia Pföhler, Anja Rudolph, Dirk Schadendorf, Maximo Schiavone, Gaston Schley, Patrick Terheyden, Selma Ugurel, Jens Ulrich, Jochen Sven Utikal, Carsten Weishaupt, Julia Welzel, Michael Weichenthal
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany. Cancers 14 (7) (2022)
Dana Westphal, M Garzarolli, M Sergon, Peter Horak, Barbara Hutter, J C Becker, M Wiegel, E Maczey, Sophia Freya Ulrike Blum, S Grosche-Schlee, A Rütten, Selma Ugurel, Albrecht Stenzinger, Hanno Glimm, Daniela E Aust, G Baretton, Stefan Beissert, Stefan Fröhling, Silke Redler, Harald M Surowy, Friedegund Meier
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma. The British journal of dermatology (2021)
R Gutzmer, H-J Schulze, Axel Hauschild, Ulrike Leiter, Friedegund Meier, S Haferkamp, C Ulrich, R U Wahl, Carola Berking, R Herbst, M Häckl, Dirk Schadendorf
Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real-world conditions in Germany - The non-interventional study NIELS. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
M S Ahmed, H Brehme, S Friedrich, Lydia Reinhardt, S Blum, S Beissert, Friedegund Meier
COVID-19 and immune checkpoint inhibitors. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (5) (2021)
Julia Höhn, Achim Hekler, Eva Krieghoff-Henning, Jakob Nikolas Kather, Jochen Sven Utikal, Friedegund Meier, Frank Friedrich Gellrich, Axel Hauschild, Lars Einar French, Justin Gabriel Schlager, Kamran Ghoreschi, Tabea Wilhelm, Heinz Kutzner, Markus Vincent Heppt, Sebastian Haferkamp, Wiebke Sondermann, Dirk Schadendorf, Bastian Schilling, Roman Christoph Maron, Max Schmitt, Tanja Jutzi, Stefan Fröhling, Daniel B Lipka, Titus Josef Brinker
Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review. Journal of medical Internet research 23 (7) (2021)
Theresa Steeb, L Reinhardt, C Görgmayr, H Weingarten, A Doppler, Julia Brütting, Friedegund Meier, Carola Berking, null null
German YouTube™ videos as a source of information on cutaneous melanoma: a critical appraisal. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (10) (2020)
Julia Brütting, Theresa Steeb, Lydia Reinhardt, Carola Berking, Friedegund Meier
Exploring the Most Visible German Websites on Melanoma Immunotherapy: A Web-Based Analysis. JMIR cancer 4 (2) (2018)
Marvin Kuske, Ricarda Rauschenberg, Marlene Garzarolli, Michelle Meredyth-Stewart, Stefan Beissert, Esther G C Troost, Oliva Isabella Claudia Glitza, Friedegund Meier
Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations-Chances and Challenges. American journal of clinical dermatology 19 (4) (2018)